Published on:

Teva, Baxter, McKesson at Fault for Hepatitis C Infections

Teva Parenteral Medicines, Inc., Baxter Healthcare Corp., and McKesson Corp. have been ordered by a jury to pay at least $20.1 million for packaging and selling an anesthetic in a way that proved harmful to patients. The jury concluded that the companies wrongfully sold Propofol in vials large enough to be used on multiple patients. Consequently, three colonoscopy patients contracted Hepatitis C. The plaintiffs sought $25 million in actual damages over the incurable liver disease. Punitive damages have yet to be decided.

Teva faces almost 300 lawsuits stemming from a Hepatitis C outbreak three years ago. The company has argued that the infections were caused by “improperly sanitized medical equipment, not reused Porpofol containers.”

About McAleer Law:

McAleer Law—Decatur, Georgia’s preeminent personal injury, worker’s compensation, and Social Security Disability firm—has been representing plaintiffs and injured workers for more than ten years. Specializing in lost wage, medical expense, pain/suffering, lost quality of life, and psychological injury cases, founder Charles McAleer guarantees his clients personal attention, diligence, and unparalleled service quality. For more information on Charles McAleer and the McAleer Law Firm visit www.McAleerLaw.com, “like” McAleer Law on Facebook, or follow @McAleerLawFirm on Twitter.